|
EIF3A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.3515000000034E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.352800E-04 |
| Normal-vs-Stage2 |
2.883500E-02 |
| Normal-vs-Stage3 |
7.83650000000247E-05 |
| Normal-vs-Stage4 |
7.353400E-04 |
| Stage1-vs-Stage2 |
7.732000E-01 |
| Stage1-vs-Stage3 |
1.499780E-01 |
| Stage1-vs-Stage4 |
3.843200E-01 |
| Stage2-vs-Stage3 |
2.078400E-01 |
| Stage2-vs-Stage4 |
3.529200E-01 |
| Stage3-vs-Stage4 |
8.337400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.214500E-04 |
| Normal-vs-AfricanAmerican |
1.252570E-01 |
| Normal-vs-Asian |
6.564300E-03 |
| Caucasian-vs-AfricanAmerican |
3.651400E-01 |
| Caucasian-vs-Asian |
9.689400E-01 |
| AfricanAmerican-vs-Asian |
4.214000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.7856999999939E-05 |
| Normal-vs-Female |
3.842200E-04 |
| Male-vs-Female |
1.541250E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.664800E-03 |
| Normal-vs-Age(41-60Yrs) |
8.3732000000003E-05 |
| Normal-vs-Age(61-80Yrs) |
9.241600E-04 |
| Normal-vs-Age(81-100Yrs) |
7.635800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.242040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.485200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.822000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.293000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.893400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.272200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.350000E-01 |
| Classical-VS-Follicular |
4.088200E-02 |
| Classical-VS-Other |
5.377200E-01 |
| Classical-VS-Normal |
5.823300E-03 |
| Tall-VS-Follicular |
7.332000E-01 |
| Tall-VS-Other |
8.993600E-01 |
| Tall-VS-Normal |
3.055800E-03 |
| Follicular-VS-Other |
9.439800E-01 |
| Follicular-VS-Normal |
1.180800E-04 |
| Other-VS-Normal |
6.637600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.72300000000192E-05 |
| Normal-vs-N1 |
4.965900E-04 |
| N0-vs-N1 |
4.365000E-01 |
|
|
